Abstract

The predictive role of high-sensitivity C-reactive protein (hs-CRP), number of tooth extractions, and oral infections for mortality in people with and without diabetes is unclear. This prospective cohort study is a 12 1/2-year follow-up of the Oslo II study, a health survey in 2000. In all, 12,764 men were invited. Health information was retrieved from 6434 elderly men through questionnaire information, serum measurements, and anthropometric and blood pressure measurements. Diabetes was reported by 425 men. Distinct differences were observed in baseline characteristics in individuals with and without diabetes. In the diabetes group, age and hs-CRP were statistically significant whereas in the nondiabetes group, age, hs-CRP, number of tooth extractions, tooth extractions for infections and oral infections combined, nonfasting glucose, systolic blood pressure, total cholesterol, regular alcohol drinking, daily smoking, and level of education were independent risk factors. The number of tooth extractions <5 was inversely related whereas more extractions increased the risk. Multivariate analyses showed that hs-CRP was a significant predictor in persons with diabetes and tooth extractions and oral infections combined; the number of teeth extracted and hs-CRP were for persons without diabetes. Infection and inflammation were associated with mortality in individuals both with and without diabetes.

Highlights

  • Diabetes is a progressive metabolic disorder with defects in insulin secretion from the beta cells and/or insulin resistance in peripheral tissues leading to chronic hyperglycaemia representing type 1 and type 2 diabetes, respectively

  • This study explores whether tooth extractions, oral infections, or high-sensitivity C-reactive protein (hs-CRP) affects mortality in people with regard to diabetes status in a 12 1/2-year follow-up of men from the Oslo II study

  • An increased level of tooth extractions due to infection was registered in individuals with diabetes (62.8%) versus those without (55.7%)

Read more

Summary

Introduction

Diabetes is a progressive metabolic disorder with defects in insulin secretion from the beta cells and/or insulin resistance in peripheral tissues leading to chronic hyperglycaemia representing type 1 and type 2 diabetes, respectively. Patients with diabetes (types 1 and 2) are at a greater risk of developing cardiovascular disease (CVD) [1,2,3]. Diabetes develops in people at different ages with type 1 most commonly among younger people and type 2 diabetes in middle to older age groups. Strøm et al report in 2006 that the sales of medication for diabetes were doubled in the last ten-year period in Norway probably due to increased prevalence and intensified treatment [5]. Recent publications indicate a slow reduction in type 2 diabetes incidence in Norway [6, 7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call